Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies von Kittai, Adam S, Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O, Okada, Craig, Park, Byung, Spurgeon, Stephen E, Danilov, Alexey V

Volltext

Reward circuit connectivity relates to delay discounting in children with attention-deficit/hyperactivity disorder von Costa Dias, Taciana G, Wilson, Vanessa B, Bathula, Deepti R, Iyer, Swathi P, Mills, Kathryn L, Thurlow, Bria L, Stevens, Corinne A, Musser, Erica D, Carpenter, Samuel D, Grayson, David S, Mitchell, Suzanne H, Nigg, Joel T, Fair, Damien A

Volltext

Altered cortico-striatal-thalamic connectivity in relation to spatial working memory capacity in children with ADHD von Mills, Kathryn L, Bathula, Deepti, Dias, Taciana G Costa, Iyer, Swathi P, Fenesy, Michelle C, Musser, Erica D, Stevens, Corinne A, Thurlow, Bria L, Carpenter, Samuel D, Nagel, Bonnie J, Nigg, Joel T, Fair, Damien A

Volltext

Final Results of a Phase 1/2 Study of SYK Inhibitor Entospletinib in Combination with Obinutuzumab in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) von Danilov, Alexey V., Lam, Vi, Thurlow, Bria, Spurgeon, Stephen E., Park, Byung, Orand, Kirsten, Kittai, Adam S

Volltext

SYK Inhibitor Entospletinib in Combination with Obinutuzumab Demonstrates Efficacy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) von Kittai, Adam S., Best, Scott R, Thurlow, Bria, Gokcora, Basak, Stadnik, Andrzej, MacKinnon, Renee, Rowland, Taylor Hashiguchi, Persky, Daniel O., Park, Byung, Spurgeon, Stephen E, Danilov, Alexey

Volltext